BRIEF-Akebia announces publication of phase 2A results for Vadadustat in patients with anemia related to chronic kidney disease
March 28 Akebia Therapeutics Inc
* Akebia Therapeutics Inc - Akebia announces publication of phase 2A results for Vadadustat in patients with anemia related to chronic kidney disease
* Akebia Therapeutics Inc - data showed Vadadustat increased hemoglobin levels and improved iron mobilization when compared to placebo Source text for Eikon: Further company coverage: